Ardelyx
Tracked across 4 events · 24 articles · First seen Apr 01, 2026 · Last active Aug 20, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Ardelyx appointed Rajani Dinavahi as its new Chief Medical Officer, which is expected to strengthen its pipeline and medical capabilities.
Apr 01, 2026 · 6 articles
Business
Impact: Ardelyx is the company hosting the earnings call to discuss its Q2 2026 financial results and business update.
Jul 23, 2026 · 6 articles
Regulatory
Ardelyx reported Q2 2026 product revenue of $118.1 million and EPS of approximately $(0.07), both below consensus. The company lowered its full-year 2026 IBSRELA revenue guidance to $350-$370 million from $410-$430 million, citing increased payer…
Impact: Ardelyx is the central company, facing a 17.86% stock drop, lowered guidance, and a securities investigation. Its credibility and future revenue outlook are negatively affected.
Aug 14, 2026 · 6 articles
Tech
Impact: Ardelyx is mentioned as Ali Rezaie, an author of the study, reports serving as a consultant for the company.
Apr 08, 2026 · 6 articles
90
Ardelyx lowered revenue guidanceArdelyx guidance cut...
80
Ardelyx scheduled earnings callArdelyx guidance cut...
70
Ardelyx withdrew revenue targetArdelyx guidance cut...
60
Levi & Korsinsky launched investigation ArdelyxArdelyx guidance cut...
ERGEN INTELLIGENCE
Track Ardelyx live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard